Enzalutamide leads to 40% lower risk of death in prostate cancer
XTANDI is the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in this patient population, supporting its earlier use in this setting
XTANDI is the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in this patient population, supporting its earlier use in this setting
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
Subscribe To Our Newsletter & Stay Updated